Why Chinese Firms’ Cross-Border Deals Fall Apart
Seeking deals opportunistically, not strategically, carries more risk.
Archive by Author
Why Apple Made the Right Call on Apple Maps
Getting control over maps is a strategic imperative, no matter the cost.
How Not to Partner in India
Lessons from a failed joint venture
The Company Outsmarting Big Pharma in Africa
How one Indian company punches above its weight in emerging markets.
Big Pharma’s Mixed Modes of Growth
Historically, big pharma firms made their own drugs. They might make a targeted acquisition here or there, form an alliance…
When to Change a Winning Strategy
Companies need to be able to grow in more than just one way – however successful they have been.
